Omeprazole in the Long-term Management of Patients with Acid-related Diseases Resistant to Ranitidine

Aenishanslin W, 1986, Schweiz Med Wochenschr, 116, 637

Arcidiacono R, 1986, Int J Clin Pharmacol Ther Toxicol, 24, 381

Farley A, 1985, Am J Gastroenterol, 80, 665

Rohner H G, 1986, Z Gastroenterol, 24, 396

Simon B, 1980, J Clin Gastroenterol, 893, 367

McFadyen M L, 1983, Eur J Clin Pharmacol, 24, 441, 10.1007/BF00609883

McFadyen M L, 1981, Scand J Gastroenterol, 16, 109

Wormsley K G, 1984, Br Med J, 289, 1095, 10.1136/bmj.289.6452.1095

Bardhan K D, 1984, Gut, 25, 711, 10.1136/gut.25.7.711

Hansen J H, 1984, Lancet, 84, 10.1016/S0140-6736(84)90251-4

Henderson R D, 1973, Can J Surg, 16, 12

Wallmark B, 1986, Scand J Gastroenterol, 21, 11, 10.3109/00365528609090881

Wallmark B, 1985, J Biol Chem, 260, 13681, 10.1016/S0021-9258(17)38778-1

Burland W L, 1980, Postgrad Med J, 56, 173, 10.1136/pgmj.56.653.173

Hentschel E, 1983, Gut, 24, 853, 10.1136/gut.24.9.853

Recard C O, 1982, Ranitidine, the selective new H2 receptor antagonist, 20

Creutzfeldt W, 1986, Digestion, 35, 84, 10.1159/000199384

Ekman L, 1985, Scand J Gastroenterol, 30, 53

Stöckmann F, 1984, Dig Dis Sci, 29, 83S

10.1159/000199381

Borch K, 1985, Gastroenterology, 88, 638, 10.1016/0016-5085(85)90131-3

Carney A, 1983, Ann Intern Med, 99, 761, 10.7326/0003-4819-99-6-761

Lattes R, 1956, Cancer, 9, 698, 10.1002/1097-0142(195607/08)9:4<698::AID-CNCR2820090412>3.0.CO;2-I

Sharma B K, 1984, Gut, 25, 957, 10.1136/gut.25.9.957

Walt R P, 1983, Br Med J, 287, 12, 10.1136/bmj.287.6384.12

Festen H PM, 1984, Gastroenterology, 87, 1030, 10.1016/S0016-5085(84)80061-X

Helander H F, 1985, Scand J Gastroenterol, 20, 19

Londong W, 1983, Gastroenterology, 85, 1373, 10.1016/S0016-5085(83)80020-1

Larsson H, 1986, Gastroenterology, 90, 391, 10.1016/0016-5085(86)90938-8

Lamberts R, 1988, Digestion, 39, 126, 10.1159/000199615